OpenVSafe by OpenVAERS
Search V-safe

75P-11825-54125

2 vaccinations 1 coded response 2 check-ins 1 free-text entry 1 call case
Sex
Female
Age at first dose
31-35
ZIP prefix
462 / IN
Registered
2021-12-20
Relationship
Self
Race
Black or African American
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-05-27
    Dose 1 — Pfizer-BioNTech
  2. 2021-12-11
    Dose 2 — Pfizer-BioNTech
  3. 2021-12-20
    Registered in v-safe
  4. 2021-12-20
    Health check-in — day 7, dose 2
    Feeling: Fair · Site: Itching · Nausea
    Adult check-in
  5. 2022-01-03
    Survey response — day 21, dose 2
    MedDRA: Nasal congestion, Respiratory tract congestion — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Stuffy nose and congestion
    MedDRA releases: 2024-11 · check-in free text available
  6. 2022-01-03
    Report sent to call center — day 21, dose 2
    Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  7. 2022-01-07

Vaccinations

DoseDateManufacturerCo-administered
12021-05-27Pfizer-BioNTech No
22021-12-11Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2022-01-03 Unsuccessful

Free text

Release 10 — day 21, dose 2

2022-01-03

Symptoms: Stuffy nose and congestion

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDNasal congestion · · ✓
SDRespiratory tract congestion · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release